BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 18648010)

  • 1. Environmental and genetic susceptibility to MLL-defined infant leukemia.
    Ross JA
    J Natl Cancer Inst Monogr; 2008; (39):83-6. PubMed ID: 18648010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights from clinical studies into the role of the MLL gene in infant and childhood leukemia.
    Chowdhury T; Brady HJ
    Blood Cells Mol Dis; 2008; 40(2):192-9. PubMed ID: 17905612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into the cellular origin and etiology of the infant pro-B acute lymphoblastic leukemia with MLL-AF4 rearrangement.
    Bueno C; Montes R; Catalina P; Rodríguez R; Menendez P
    Leukemia; 2011 Mar; 25(3):400-10. PubMed ID: 21135858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Risk-adapted therapeutic stratification of infantile acute lymphocytic leukemia based on MLL-gene rearrangement].
    Tomizawa D
    Rinsho Ketsueki; 2008 Mar; 49(3):171-81. PubMed ID: 18421958
    [No Abstract]   [Full Text] [Related]  

  • 5. D-HPLC analysis of the entire FLT3 gene in MLL rearranged and hyperdiploid acute lymphoblastic leukemia.
    Stam RW; den Boer ML; Schneider P; Meier M; Beverloo HB; Pieters R
    Haematologica; 2007 Nov; 92(11):1565-8. PubMed ID: 18024407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features, molecular diagnosis, and treatment outcome of infants with leukemia in Taiwan.
    Chen SH; Yang CP; Hung IJ; Jaing TH; Shih LY; Tsai MH
    Pediatr Blood Cancer; 2010 Dec; 55(7):1264-71. PubMed ID: 20979094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytogenetic and molecular analysis of MLL rearrangements in acute lymphoblastic leukaemia survivors.
    Brassesco MS; Montaldi AP; Gras DE; Camparoto ML; Martinez-Rossi NM; Scrideli CA; Tone LG; Sakamoto-Hojo ET
    Mutagenesis; 2009 Mar; 24(2):153-60. PubMed ID: 19028982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Leukemia in neonates and infants].
    Sońta-Jakimczyk D; Szczepański T
    Przegl Lek; 2003; 60 Suppl 5():9-12. PubMed ID: 14575001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MLL-AF9 leukemia stem cells: hardwired or taking cues from the microenvironment?
    Muntean AG; Hess JL
    Cancer Cell; 2008 Jun; 13(6):465-7. PubMed ID: 18538728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel t(4;11)(q21;q23) MLL-AF4 fusion transcript in infant leukemia.
    Abdelhaleem M; Yi Q; Beimnet K; Grant R
    Am J Hematol; 2007 Mar; 82(3):247. PubMed ID: 16924642
    [No Abstract]   [Full Text] [Related]  

  • 11. Genetic variants modify susceptibility to leukemia in infants: a Children's Oncology Group report.
    Ross JA; Linabery AM; Blommer CN; Langer EK; Spector LG; Hilden JM; Heerema NA; Radloff GA; Tower RL; Davies SM
    Pediatr Blood Cancer; 2013 Jan; 60(1):31-4. PubMed ID: 22422485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel AF9 breakpoint in MLL-AF9-positive acute monoblastic leukemia.
    Alonso CN; Longo PL; Gallego MS; Medina A; Felice MS
    Pediatr Blood Cancer; 2008 Apr; 50(4):869-71. PubMed ID: 18000862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excess congenital non-synonymous variation in leukemia-associated genes in MLL- infant leukemia: a Children's Oncology Group report.
    Valentine MC; Linabery AM; Chasnoff S; Hughes AE; Mallaney C; Sanchez N; Giacalone J; Heerema NA; Hilden JM; Spector LG; Ross JA; Druley TE
    Leukemia; 2014 Jun; 28(6):1235-41. PubMed ID: 24301523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MLL gene rearrangements in infant leukemia vary with age at diagnosis and selected demographic factors: a Children's Oncology Group (COG) study.
    Sam TN; Kersey JH; Linabery AM; Johnson KJ; Heerema NA; Hilden JM; Davies SM; Reaman GH; Ross JA
    Pediatr Blood Cancer; 2012 Jun; 58(6):836-9. PubMed ID: 21800415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new chromosomal three-way rearrangement involving MLL masked by a t(9;19)(p11;p13) in an infant with acute myeloid leukemia.
    de Jesus Marques-Salles T; Liehr T; Mkrtchyan H; Raimondi SC; Tavares de Souza M; de Figueiredo AF; Rouxinol S; Jordy Macedo FC; Abdelhay E; Santos N; Macedo Silva ML
    Cancer Genet Cytogenet; 2009 Feb; 189(1):59-62. PubMed ID: 19167614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute megakaryoblastic leukemia in a child with the MLL-AF4 fusion gene.
    Takita J; Motomura A; Koh K; Ida K; Taki T; Hayashi Y; Igarashi T
    Eur J Haematol; 2009 Aug; 83(2):149-53. PubMed ID: 19459927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Versican expression is an adverse prognostic factor in MLL-rearranged infant acute lymphoblastic leukaemia.
    Driessen EM; Pinhanços SS; Schneider P; de Lorenzo P; Valsecchi MG; Pieters R; Stam RW
    Eur J Cancer; 2016 Apr; 57():87-90. PubMed ID: 26901613
    [No Abstract]   [Full Text] [Related]  

  • 18. Association of MLL amplification with poor outcome in acute myeloid leukemia.
    Maitta RW; Cannizzaro LA; Ramesh KH
    Cancer Genet Cytogenet; 2009 Jul; 192(1):40-3. PubMed ID: 19480936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical efficacy of gemcitabine in MLL-rearranged infant acute lymphoblastic leukemia.
    Wander P; Cheung LC; Pinhanҫos SS; Jones L; Kerstjens M; Arentsen-Peters STCJM; Singh S; Chua GA; Castro PG; Schneider P; Dolman MEM; Koopmans B; Molenaar JJ; Pieters R; Zwaan CM; Kotecha RS; Stam RW
    Leukemia; 2020 Nov; 34(11):2898-2902. PubMed ID: 32488115
    [No Abstract]   [Full Text] [Related]  

  • 20. Intensified chemotherapy without SCT in infant ALL: results from COG P9407 (Cohort 3).
    Dreyer ZE; Hilden JM; Jones TL; Devidas M; Winick NJ; Willman CL; Harvey RC; Chen IM; Behm FG; Pullen J; Wood BL; Carroll AJ; Heerema NA; Felix CA; Robinson B; Reaman GH; Salzer WL; Hunger SP; Carroll WL; Camitta BM
    Pediatr Blood Cancer; 2015 Mar; 62(3):419-26. PubMed ID: 25399948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.